Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. [electronic resource]
Producer: 20130116Description: 13-22 p. digitalISSN:- 1872-6240
- Amphetamine
- Analysis of Variance
- Animals
- Atorvastatin
- Corpus Striatum -- drug effects
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Interactions
- Enzyme-Linked Immunosorbent Assay
- Glutathione -- metabolism
- Heptanoic Acids -- therapeutic use
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Interleukin-6 -- metabolism
- Male
- Malondialdehyde -- metabolism
- Mitochondria -- drug effects
- Motor Activity -- drug effects
- NADH Dehydrogenase -- metabolism
- Nitrites -- metabolism
- Oxidopamine -- toxicity
- Parkinsonian Disorders -- chemically induced
- Pyrroles -- therapeutic use
- Rats
- Rats, Wistar
- Simvastatin -- therapeutic use
- Tetrazolium Salts
- Thiazoles
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.